Growth Ready Alba Therapeutics is a small-to-mid-sized biotech with 11-50 employees and roughly $10-25M in revenue, indicating growth potential and a need for scalable, cost-efficient solutions that support expanding R&D programs.

R&D Partnerships As an active biotech research company, Alba could benefit from CRO/CDMO partnerships, outsourced data management, and bioinformatics to accelerate project timelines and reduce internal burden.

Tech Modernization The tech stack combines legacy components (PHP, jQuery, Nginx) with modern tools (Module Federation, Webpack), signaling an opportunity for IT modernization, cloud adoption, and security/compliance upgrades.

Talent Optimization They already use iCIMS for recruitment, suggesting a foothold for expanded talent acquisition optimization with biotech-focused recruiting tools, integrations, and candidate experience enhancements.

US Market Fit Based in the United States with a mid-market profile, Alba is a good fit for suppliers of lab reagents, instrumentation, and outsourced R&D or clinical services targeting mid-sized biotech firms.